Herpesvirus latency confers symbiotic protection from bacterial infection

被引:560
作者
Barton, Erik S.
White, Douglas W.
Cathelyn, Jason S.
Brett-McClellan, Kelly A.
Engle, Michael
Diamond, Michael S.
Miller, Virginia L.
Virgin, Herbert W.
机构
[1] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA
[5] Washington Univ, Sch Med, Div Rheumatol, St Louis, MO 63110 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/nature05762
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
All humans become infected with multiple herpesviruses during childhood. After clearance of acute infection, herpesviruses enter a dormant state known as latency. Latency persists for the life of the host and is presumed to be parasitic, as it leaves the individual at risk for subsequent viral reactivation and disease(1). Here we show that herpesvirus latency also confers a surprising benefit to the host. Mice latently infected with either murine gammaherpesvirus 68 or murine cytomegalovirus, which are genetically highly similar to the human pathogens Epstein - Barr virus and human cytomegalovirus(2), respectively, are resistant to infection with the bacterial pathogens Listeria monocytogenes and Yersinia pestis. Latency-induced protection is not antigen specific but involves prolonged production of the antiviral cytokine interferon-gamma and systemic activation of macrophages. Latency thereby upregulates the basal activation state of innate immunity against subsequent infections. We speculate that herpesvirus latency may also sculpt the immune response to self and environmental antigens through establishment of a polarized cytokine environment. Thus, whereas the immune evasion capabilities and lifelong persistence of herpesviruses are commonly viewed as solely pathogenic, our data suggest that latency is a symbiotic relationship with immune benefits for the host.
引用
收藏
页码:326 / U7
页数:5
相关论文
共 30 条
[1]   Characterization of the CD4+T cell response Epstein-Barr virus during primary and persistent infection [J].
Amyes, E ;
Hatton, C ;
Montamat-Sicotte, D ;
Gudgeon, N ;
Rickinson, AB ;
McMichael, AJ ;
Callan, MFC .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (06) :903-911
[2]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[3]   Memory CD8+ T cells provide innate immune protection against Listeria monocytogenes in the absence of cognate antigen [J].
Berg, RE ;
Crossley, E ;
Murray, S ;
Forman, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (10) :1583-1593
[4]  
Braaten Douglas C, 2006, PLoS Pathog, V2, pe37, DOI 10.1371/journal.ppat.0020037
[5]   RovA, a global regulator of Yersinia pestis, specifically required for bubonic plague [J].
Cathelyn, Jason S. ;
Crosby, Seth D. ;
Lathem, Wyndham W. ;
Goldman, William E. ;
Miller, Virginia L. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (36) :13514-13519
[6]   Quantitative analysis of the acute and long-term CD4+ T-cell response to a persistent gammaherpesvirus [J].
Christensen, JP ;
Doherty, PC .
JOURNAL OF VIROLOGY, 1999, 73 (05) :4279-4283
[7]   Dynamics of CD4 and CD8 T cell responses to cytomegalovirus in healthy human donors [J].
Dunn, HS ;
Haney, DJ ;
Ghanekar, SA ;
Stepick-Biek, P ;
Lewis, DB ;
Maecker, HT .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (01) :15-22
[8]   Immunity to Listeria infection [J].
Edelson, BT ;
Unanue, ER .
CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (04) :425-431
[9]   Intracellular antibody neutralizes Listeria growth [J].
Edelson, BT ;
Unanue, ER .
IMMUNITY, 2001, 14 (05) :503-512
[10]   Analysis of virus-specific CD4+ T cells during long-term gammaherpesvirus infection [J].
Flaño, E ;
Woodland, DL ;
Blackman, MA ;
Doherty, PC .
JOURNAL OF VIROLOGY, 2001, 75 (16) :7744-7748